• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    H

    Hospital Pró-Cardíaco

    EST. 1959
    213论文总数
    2,091引用总数

    论文量&引用量时间轴

    机构学者

    论文(213)

    年份
    起
    –
    止
    排序
    1Brain Frailty Rather Than Age Alone Mediates the Lack of Benefit for Endovascular Thrombectomy in the Elderly Population of the RESILIENT Trial
    Rui Kleber do Vale Martins-Filho, Thiago Oscar Goulart, Octavio Marques Pontes-Neto,Fabricio O Lima,Leticia C Rebello, Mario B Faria,Francisco Mont'Alverne, Bruno S M Parente, Leonardo A Carbonera,Millene Rodrigues Camilo, Diego Bandeira, Gisele S Silva,

    OBJECTIVE:The objective of this study was to determine whether baseline computed tomography (CT) markers of cerebral small vessel disease (cSVD), as a surrogate of brain frailty, explain the association between age and functional outcome, potentially accounting for the reduced apparent benefit of mechanical thrombectomy (MT) in elderly patients in the RESILIENT trial. METHODS:RESILIENT was a multicenter, prospective, randomized, open-label trial with blinded outcome assessment conducted in Brazil. Patients with anterior circulation large-vessel occlusion stroke were randomized to MT plus guideline-based care or guideline-based care alone, including intravenous alteplase when eligible. A vascular neurologist blinded to clinical data evaluated baseline CT scans for cSVD markers (leukoaraiosis, lacunes, and atrophy) to derive a composite cSVD score. Multivariable logistic regression identified independent predictors of good functional outcome (modified Rankin Scale [mRS] = 0-2 at 90 days). Treatment effects were assessed across subgroups defined by age (<70 or ≥70 years) and cSVD score (0-1 vs 2-3). Mediation analysis quantified the indirect effect of age on outcome through cSVD. RESULTS:Patients with good outcomes were younger, had lower National Institutes of Health Stroke Scale (NIHSS) scores, better collaterals, lower glucose levels, lower cSVD burden, and were more frequently treated with MT. Independent predictors of good outcome included lower NIHSS, MT, lower cSVD score, and lower glucose levels. MT benefit was restricted to patients <70 years with low cSVD burden (odds ratio [OR] = 4.16, 95% confidence interval [CI] = 1.6-10.4, p < 0.01). No benefit was observed in older patients or in those with cSVD > 1. Mediation analysis showed that cSVD significantly mediated the association between age and outcome (average causal mediation effect [ACME] = -0.003, 95% CI = -0.005 to 0.00, p = 0.010). INTERPRETATION:Baseline CT markers of cSVD were independently associated with poorer outcomes and mediated the association between age and functional outcome in the RESILIENT trial, potentially explaining the lack of MT efficacy in older patients. ANN NEUROL 2026;100:361-369.

    2026Annals of neurology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Biomarker-Imaging Dissociation in Wild-Type Cardiac Amyloidosis after Treatment with Patisiran.
    Claudio Tinoco Mesquita, Davi Shunji Yahiro, Roberta Pereira Dos Santos Coelho, Giovane Leal de Azevedo Junior, Beatriz Robert Moreira, Régina Limongi de Figueiredo, Eliza Gripp, Diane Xavier Ávila
    2026Arquivos brasileiros de cardiologia(2026)
    引用
    AI阅读
    加入学术空间
    3Como Eu Faço O Acompanhamento Da Valvoplastia Mitral Percutânea Por Balão
    Eliza de Almeida Gripp, Bernardo Nascimento Lourenço, Larissa Ribas Carestiato, Marcelo Lemos Ribeiro,Leandro Assumpção Côrtes,Arnaldo Rabischoffsky

    Resumo A doença cardíaca reumática (DCR) permanece como importante problema de saúde pública em âmbito mundial, em razão de sua elevada morbimortalidade, acometendo preferencialmente a valva mitral. Embora apresente maior prevalência em países em desenvolvimento, a doença também é diagnosticada, ainda que com menor frequência, em países desenvolvidos. Nesse contexto, a valvoplastia mitral percutânea por balão (VMPB) consolidou-se como uma modalidade terapêutica altamente eficaz para pacientes selecionados, sendo seu sucesso técnico e clínico fortemente dependente de uma criteriosa seleção dos candidatos ao procedimento. O presente artigo tem como objetivo revisar os principais aspectos relacionados à VMPB, desde os critérios ecocardiográficos empregados na seleção dos pacientes até a monitorização intraprocedimento por meio do ecodopplercardiograma transesofágico (ETE).

    2026ABC Imagem Cardiovascular(2026)
    引用
    AI阅读
    加入学术空间
    4Guideline on Stress Echocardiography - 2026.
    Ana Cristina Camarozano,Salvador Vicente Spina,José Roberto Matos Souza,Marcelo Dantas Tavares de Melo,Daniela do Carmo Rassi Frota,Silvio Henrique Barberato,Fabio Villaça Guimarães Filho,Harry Acquatella, Vera Márcia Lopes Gimenes, Jorge Alfredo Lowenstein,Ricardo H Pignatelli,José Maria Del Castillo,
    2026Arquivos brasileiros de cardiologia(2026)
    引用
    AI阅读
    加入学术空间
    5My Approach to Echocardiographic Guidance During Percutaneous Balloon Mitral Valvuloplasty
    Eliza de Almeida Gripp, Bernardo Nascimento Lourenço, Larissa Ribas Carestiato, Marcelo Lemos Ribeiro,Leandro Assumpção Côrtes,Arnaldo Rabischoffsky

    Abstract Rheumatic heart disease (RHD) remains a major global public health challenge because of its substantial morbidity and mortality, predominantly affecting the mitral valve. Although its prevalence is higher in developing countries, the disease continues to be diagnosed, albeit less frequently, in developed nations. Percutaneous balloon mitral valvuloplasty (PBMV) has become a highly effective therapeutic option for appropriately selected patients, with its technical and clinical success being strongly dependent on careful candidate selection. This article reviews the key aspects of PBMV, ranging from the echocardiographic criteria used for patient selection to intraprocedural monitoring using transesophageal echocardiography (TEE).

    2026ABC Imagem Cardiovascular(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 213 篇论文

    合作机构(100)

    里约热内卢州立大学合作论文 32
    里约热内卢联邦大学合作论文 30
    弗鲁米嫩塞联邦大学合作论文 27
    圣保罗大学合作论文 17
    Instituto Nacional de Cardiologia合作论文 13
    圣保罗联邦大学合作论文 12
    Hospital Israelita Albert Einstein合作论文 11
    Instituto Dante Pazzanese de Cardiologia合作论文 10
    南里奥格兰德联邦大学合作论文 9
    Federal University of Paraíba合作论文 7

    机构统计